Growing community of inventors

Kembs, France

Xavier Francois Andre Pelle

Average Co-Inventor Count = 9.64

ph-index = 3

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 12

Xavier Francois Andre PellePascal Furet (6 patents)Xavier Francois Andre PellePaul William Manley (6 patents)Xavier Francois Andre PelleJoseph Schoepfer (6 patents)Xavier Francois Andre PelleAndreas Marzinzik (6 patents)Xavier Francois Andre PelleWolfgang Jahnke (6 patents)Xavier Francois Andre PelleBahaa Salem (6 patents)Xavier Francois Andre PelleRobert Martin Grotzfeld (6 patents)Xavier Francois Andre PelleDarryl Jones (6 patents)Xavier Francois Andre PelleSaliha Moussaoui (2 patents)Xavier Francois Andre PelleStephanie Kay Dodd (1 patent)Xavier Francois Andre PelleErich Alois Spieser (1 patent)Xavier Francois Andre PelleXavier Francois Andre Pelle (6 patents)Pascal FuretPascal Furet (97 patents)Paul William ManleyPaul William Manley (63 patents)Joseph SchoepferJoseph Schoepfer (13 patents)Andreas MarzinzikAndreas Marzinzik (9 patents)Wolfgang JahnkeWolfgang Jahnke (7 patents)Bahaa SalemBahaa Salem (7 patents)Robert Martin GrotzfeldRobert Martin Grotzfeld (7 patents)Darryl JonesDarryl Jones (6 patents)Saliha MoussaouiSaliha Moussaoui (4 patents)Stephanie Kay DoddStephanie Kay Dodd (12 patents)Erich Alois SpieserErich Alois Spieser (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Novartis Ag (5 from 3,923 patents)

2. Novatis Ag (1 from 5 patents)


6 patents:

1. 9896444 - Benzamide derivatives for inhibiting the activity of ABL1, ABL2 and BCR-ABL1

2. 9458112 - Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1

3. 9340537 - Benzamide derivatives for inhibiting the activity of ABL1, ABL2 and BCR-ABL1

4. 9315489 - Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1

5. 9278981 - Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1

6. 8829195 - Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/4/2025
Loading…